T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination

Area of Science:

• Immunology
• Vaccinology
• Infectious Diseases
• Public Health

Background:

• Invasive Haemophilus influenzae type b (Hib) infections are occurring in a small number of fully vaccinated children in the UK.
• Recent years have seen a rise in Hib disease, linked to declining vaccine-induced antibody levels in early childhood.
• Protection increasingly relies on immunological memory, necessitating interventions like catch-up vaccination campaigns.

Purpose of the Study:

• To investigate the reasons behind the resurgence of invasive Hib infections in vaccinated UK children.
• To explore the potential role of vaccine-induced immune responses and natural boosting in disease incidence.
• To assess the implications for current and future conjugate vaccine strategies.

Main Methods:

• Analysis of invasive Hib infection cases in fully vaccinated children.
• Evaluation of vaccine-induced antibody levels and immunological memory.
• Assessment of Hib circulation patterns and potential impact on natural boosting.

Main Results:

• A rise in invasive Hib infections observed in fully vaccinated children.
• Lower vaccine-induced antibody levels noted in the first five years of life.
• Potential contribution of impaired T cell response and reduced natural boosting to increased disease incidence.

Conclusions:

• The conjugate vaccine's limitations in inducing specific helper T cells and reduced natural boosting may contribute to rising invasive Hib disease.
• The findings suggest that the vaccine may not fully activate all necessary immune system components.
• This has significant implications for the scheduling and design of other conjugate vaccines, including those for meningococcal and pneumococcal diseases.